KRISTIN COLLINS: Open Payments
NPI 1134511694 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 21 payments from 10 companies in 2025. Trend: 2023 $2,552 · 2024 $2,480 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $370 |
| Ardelyx, Inc. | 2 | $248 |
| Janssen Biotech, Inc. | 4 | $184 |
| GENZYME CORPORATION | 2 | $114 |
| Medtronic, Inc. | 1 | $82 |
| Madrigal Pharmaceuticals | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Organon LLC | 2 | $28 |
| Fresenius Kabi USA, LLC | 1 | $20 |
Products named: IBSRELA, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, MAVYRET, ENDOFLIP, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
